Bulk Pharmaceutical API Sources for pentazocine lactate

Bulk Pharmaceutical API Sources for pentazocine lactate

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		656697
THE BioTek		bt-278517
Smolecule		S538982
BenchChem		B1679296
CymitQuimica		CQ_17146-95-1
RR Scientific		R5864554

Bulk Active Pharmaceutical Ingredient (API) Sources for: Pentazocine Lactate

Last updated: August 5, 2025

---

Introduction

Pentazocine lactate is a synthetic opioid analgesic used primarily for moderate to severe pain management. As an essential API in pharmaceutical manufacturing, its sourcing holds significant strategic importance for pharmaceutical companies, wholesalers, and healthcare providers. Reliable API sources ensure product quality, regulatory compliance, and supply chain stability. This article examines the global landscape of pentazocine lactate API suppliers, analyzing key regions, manufacturer credentials, and procurement considerations.

Global API Manufacturing Landscape for Pentazocine Lactate

The API market for pentazocine lactate is characterized by a handful of specialized chemical manufacturers primarily based in India, China, and to a lesser extent, Europe. Among these, Indian companies dominate the global production due to their cost competitiveness, extensive pharmacopoeia compliance, and established export infrastructure.

Leading API Suppliers in India

India's pharmaceutical industry has long been recognized as a global API manufacturing hub, supported by a robust regulatory framework, a large pool of chemical engineers, and export-friendly policies. For pentazocine lactate alone, several API manufacturers supply bulk quantities to multinational pharmaceutical firms.

Syngine Pharma

Syngine Pharma is an Indian API producer specializing in opioids and analgesics, including pentazocine lactate. The company emphasizes strict adherence to cGMP standards, offering APIs that meet US FDA, EMA, and WHO certifications. Their capacity allows for both large-scale manufacturing and custom synthesis.

Hetero Labs

Hetero Labs has a notable presence in the analgesic API sector, with extensive expertise in synthetic opioids. Their pentazocine lactate products are known for high purity, consistent quality, and competitive pricing. Hetero maintains comprehensive certifications, including ISO and cGMP compliance.

Sun Pharma

While primarily a finished drug manufacturer, Sun Pharma also supplies APIs like pentazocine lactate through its CDMO (Contract Development and Manufacturing Organization) services. Their API production facilities are compliant with global standards, making them a dependable source.

Jubilant Pharmova

Jubilant Pharmova's API division is a prominent player, offering pentazocine lactate with rigorous quality controls. Their extensive API portfolio and global distribution capabilities make them a strategic supplier for large-volume procurement.

Chinese API Manufacturers

China remains a significant player in the API manufacturing domain, with several producers offering cost-effective options for pentazocine lactate.

Wuxi AppTec

Wuxi AppTec provides a broad API portfolio that includes opioids. Their quality systems are aligned with international standards, and they serve clients across North America, Europe, and Asia.

Hepeng Pharmaceutical

Hepeng specializes in synthetic opioids and offers pentazocine lactate APIs with competitive pricing and regulatory filings in multiple regions. Their manufacturing facilities are compliant with GMP standards.

European and Other North American API Providers

European and North American manufacturers are fewer but tend to offer APIs with the highest regulatory credibility, mainly catering to highly regulated markets.

CoreRx Inc.

Based in the US, CoreRx supplies high-quality APIs and intermediates, including pentazocine lactate, emphasizing compliance with FDA standards. Their focus on quality assurance makes them suitable for strict regulatory environments.

Polpharma

Polpharma, based in Poland, is a significant European API manufacturer with a portfolio spanning generic drugs and APIs, including opioids. Their manufacturing facilities are GMP-certified.

Procurement Considerations

When sourcing pentazocine lactate API, several factors influence decision-making:

• Regulatory Compliance: Ensure supplier adherence to cGMP, ISO, and relevant pharmacopoeial standards.
• Certification and Documentation: Verify Certificates of Analysis (CoA), Certificates of Suitability (CEPs), DMFs, and other regulatory documents.
• Quality Consistency: Opt for suppliers with proven quality track records and capacity for batch-to-batch consistency.
• Supply Chain Reliability: Consider regional proximity, logistical capabilities, and supply stability amid global disruptions.
• Pricing and Lead Times: Balance cost advantages with quality and delivery timelines, especially for high-volume needs.

Regulatory and Quality Assurance Challenges

API sourcing for pentazocine lactate involves navigating complex regulatory landscapes, including compliance with the Drug Master Files (DMF) and maintaining transparency in manufacturing processes. Manufacturers must also demonstrate control over synthesis pathways to prevent contamination and ensure low impurity profiles, critical for opioids with stringent pharmacopoeial standards.

Emerging Trends and Future Outlook

The API market for pentazocine lactate is experiencing increased scrutiny due to global opioid regulations and geopolitical considerations. Manufacturers investing in advanced synthesis techniques and Quality by Design (QbD) processes aim to enhance API purity and reduce impurities. Additionally, regional diversification of supply sources is increasingly prioritized to mitigate risks associated with geopolitical tensions and supply chain disruptions.

---

Key Takeaways

• The Indian market dominates pentazocine lactate API supply, supported by established manufacturing capacity, cost advantages, and global certifications.
• Chinese suppliers offer cost-effective alternatives with increasing focus on compliance with international standards.
• European and North American manufacturers provide high-quality APIs suited for highly regulated markets, albeit at potentially higher costs.
• Due diligence in regulatory compliance, quality assurance, and supply chain resilience remains critical in API sourcing.
• Emerging synthesis innovations and regional diversification efforts are shaping the future landscape of pentazocine lactate API procurement.

---

Frequently Asked Questions

Q1: Which are the most reliable API manufacturers for pentazocine lactate?
A1: Leading Indian manufacturers such as Hetero Labs, Jubilant Pharmova, and Syngine Pharma are known for their compliance with international standards and consistent quality.

Q2: What regulatory certifications should API suppliers for pentazocine lactate possess?
A2: Suppliers should hold cGMP certification, COA, CEPs, DMFs, and ISO certifications to ensure regulatory compliance and quality.

Q3: How does regional origin affect API quality and regulatory acceptance?
A3: North American and European suppliers often offer APIs with proven compliance for rigorous markets, while Indian and Chinese manufacturers tend to be cost-effective but require diligent validation of regulatory credentials.

Q4: What are the current trends in sourcing APIs like pentazocine lactate?
A4: Trends include increased regional diversification, investment in advanced synthesis technologies, and heightened focus on quality assurance amid tightening global opioid regulations.

Q5: What logistical factors influence the procurement of pentazocine lactate API?
A5: Consider proximity to manufacturing facilities, supply chain resilience, customs regulations, and lead times to ensure continuous supply and regulatory compliance.

---

References

1. U.S. Food and Drug Administration. (2022). Guidance for Industry: Quality System Approach to Pharmaceutical Quality.
2. WHO Expert Committee on Specifications for Pharmaceutical Preparations. (2020). WHO Technical Report Series, No. 1020.
3. Indian Pharmaceutical Alliance. (2021). Market Report on API Manufacturing in India.
4. European Medicines Agency. (2022). Good Manufacturing Practice (GMP) compliance guidance.
5. Chinese State Food and Drug Administration. (2020). Regulatory standards for API manufacturing.